A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease
NCT00248352 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 212
Last updated 2007-10-26
Summary
The purpose of this study is to compare two ways to treat patients with Type 2 Diabetes, Standard Care or Case-Managed Care.
In-Patient Standard Care is guided by the assigned cardiologist and Out-Patient Standard Care by the existing diabetes care givers.
Case-Managed care involves a consult with an endocrinologist and counseling from a diabetic educator and a dietician.
Conditions
- Diabetes Mellitus, Type 2
- Coronary Disease
Interventions
- BEHAVIORAL
-
Consultation with Endocrinologist
- BEHAVIORAL
-
Counseling from Dietician
- BEHAVIORAL
-
Counseling from Diabetes Educator
Sponsors & Collaborators
Principal Investigators
-
Richard F. Davies, M.D. · University of Ottawa Heart Instittue
-
Janine Malcolm, M.D. · Ottawa Hospital
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-02-28
- Completion
- 2007-10-31
Countries
- Canada
Study Locations
More Related Trials
-
Inpatient Diabetes on Corticosteroids
NCT01970241 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
NCT00418288 ·Status: COMPLETED ·Phase: NA
-
Low Glycemic Index Diet in Patients With Type 1 Diabetes
NCT01184703 ·Status: COMPLETED ·Phase: PHASE3
-
Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance
NCT01173978 ·Status: COMPLETED ·Phase: NA
-
Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
NCT04449692 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
NCT01931982 ·Status: COMPLETED ·Phase: PHASE4
-
Lifestyle Control of Postprandial Hyperglycemia
NCT02683135 ·Status: COMPLETED ·Phase: NA
-
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
NCT05502562 ·Status: COMPLETED
-
Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus
NCT00655603 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
NCT01300260 ·Status: COMPLETED ·Phase: PHASE1
-
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
NCT03914326 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
NCT00732602 ·Status: COMPLETED ·Phase: NA
-
Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy
NCT00935805 ·Status: UNKNOWN
-
The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.
NCT04472962 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes
NCT04193566 ·Status: COMPLETED ·Phase: PHASE4
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA
-
Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?
NCT02280837 ·Status: COMPLETED
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Importance in Type 1 Diabetes Patients of an Optimized Control of Post-Prandial Glycaemia on Oxidant Stress Prevention
NCT00934336 ·Status: COMPLETED ·Phase: NA
-
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
NCT07073053 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
Glucagon-Like Peptide-1 (GLP-1) Suppression of Alpha Cell Secretion in Type 2 Diabetes Mellitus (T2DM)
NCT00862589 ·Status: COMPLETED ·Phase: NA
-
Characterization of Beta Cell Failure
NCT00869102 ·Status: WITHDRAWN ·Phase: NA
-
Dietary Strategies for Remission of Type 2 Diabetes
NCT04943926 ·Status: RECRUITING ·Phase: NA